Trademarkia Logo

Australia

AU$
Trademark Search
PEG-FUSION

View On IPO.GOV.AU

PEG-FUSION
Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

Neuraptive Therapeutics, Inc.

168 CTC Blvd., Suite E

Louisville CO 80027, UNITED STATES OF AMERICA

Serial Number

2324725 filed on 14 Oct 2022

Correspondent

Knobbe, Martens, Olson & Bear, LLP

2040 Main Street, 14th Floor,

Irvine CA 92614,

UNITED STATES OF AMERICA

PEG-FUSION

Classification Information

Class [005]
Pharmaceutical preparations for use on the peripheral or central nervous system for the treatment of damaged or severed nerves; surgical implants comp Read More

Class [010]
Drug delivery system for delivering pharmaceutical preparations for use on the peripheral and central nervous system.

Mark Details

Serial Number

2324725

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

18 Apr 2022

Mark Type

US

Legal History

Show more

Status DateAction Taken
12th Feb 2025Status change to Voided
4th May 2024International Registration in Australia Refused correspondence sent
3rd May 2024Status change to Lapsed/Not Protected
30th Dec 2023IRDA - Opposition Still Possible Notice correspondence sent
27th Jan 2023Adverse Report (Examination) correspondence sent
26th Jan 2023IP Right has been Examined
12th Jan 2023Awaiting examination
12th Jan 2023Examination expedited
29th Dec 2022IP Right Filed Published
29th Dec 2022Status change to Published